averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-21-5p
|
MIMAT0000076 |
hsa-miR-590-5p
|
MIMAT0003258 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_139876812 | 10.19 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chrX_-_18372792 | 9.34 |
ENST00000251900.4
|
SCML2
|
sex comb on midleg-like 2 (Drosophila) |
chr22_+_33197683 | 8.91 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
chr7_-_44924939 | 7.48 |
ENST00000395699.2
|
PURB
|
purine-rich element binding protein B |
chr4_+_124320665 | 6.65 |
ENST00000394339.2
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr3_-_18466787 | 6.60 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
chr10_+_112631547 | 6.34 |
ENST00000280154.7
ENST00000393104.2 |
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor) |
chr17_+_17942594 | 6.25 |
ENST00000268719.4
|
GID4
|
GID complex subunit 4 |
chr7_+_102715315 | 6.22 |
ENST00000428183.2
ENST00000323716.3 ENST00000441711.2 ENST00000454559.1 ENST00000425331.1 ENST00000541300.1 |
ARMC10
|
armadillo repeat containing 10 |
chr2_-_43453734 | 6.14 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
chr2_-_37193606 | 6.11 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
chr16_-_75498553 | 5.87 |
ENST00000569276.1
ENST00000357613.4 ENST00000561878.1 ENST00000566980.1 ENST00000567194.1 |
TMEM170A
RP11-77K12.1
|
transmembrane protein 170A Uncharacterized protein |
chr13_-_41706864 | 5.27 |
ENST00000379485.1
ENST00000499385.2 |
KBTBD6
|
kelch repeat and BTB (POZ) domain containing 6 |
chr5_-_160973649 | 5.10 |
ENST00000393959.1
ENST00000517547.1 |
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
chrX_-_54384425 | 5.05 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr4_+_113152881 | 4.57 |
ENST00000274000.5
|
AP1AR
|
adaptor-related protein complex 1 associated regulatory protein |
chr8_-_57123815 | 4.46 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
chr1_-_207224307 | 4.44 |
ENST00000315927.4
|
YOD1
|
YOD1 deubiquitinase |
chr5_+_56111361 | 4.40 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr2_-_64371546 | 4.32 |
ENST00000358912.4
|
PELI1
|
pellino E3 ubiquitin protein ligase 1 |
chr16_-_4292071 | 4.24 |
ENST00000399609.3
|
SRL
|
sarcalumenin |
chr7_+_138916231 | 4.11 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr9_+_36036430 | 4.01 |
ENST00000377966.3
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs |
chr13_+_73632897 | 3.87 |
ENST00000377687.4
|
KLF5
|
Kruppel-like factor 5 (intestinal) |
chr1_-_72748417 | 3.72 |
ENST00000357731.5
|
NEGR1
|
neuronal growth regulator 1 |
chr3_-_24536253 | 3.71 |
ENST00000428492.1
ENST00000396671.2 ENST00000431815.1 ENST00000418247.1 ENST00000416420.1 ENST00000356447.4 |
THRB
|
thyroid hormone receptor, beta |
chr11_+_33278811 | 3.49 |
ENST00000303296.4
ENST00000379016.3 |
HIPK3
|
homeodomain interacting protein kinase 3 |
chr8_-_82024290 | 3.41 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
chr8_-_9008206 | 3.27 |
ENST00000310455.3
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B |
chr11_-_64646086 | 3.27 |
ENST00000320631.3
|
EHD1
|
EH-domain containing 1 |
chr1_+_203274639 | 3.18 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
chr10_+_72164135 | 3.17 |
ENST00000373218.4
|
EIF4EBP2
|
eukaryotic translation initiation factor 4E binding protein 2 |
chr8_+_98881268 | 3.16 |
ENST00000254898.5
ENST00000524308.1 ENST00000522025.2 |
MATN2
|
matrilin 2 |
chr17_+_59477233 | 3.09 |
ENST00000240328.3
|
TBX2
|
T-box 2 |
chr5_-_32313019 | 3.00 |
ENST00000280285.5
ENST00000264934.5 |
MTMR12
|
myotubularin related protein 12 |
chr16_+_12070567 | 2.92 |
ENST00000566228.1
|
SNX29
|
sorting nexin 29 |
chr2_-_201936302 | 2.88 |
ENST00000453765.1
ENST00000452799.1 ENST00000446678.1 ENST00000418596.3 |
FAM126B
|
family with sequence similarity 126, member B |
chr1_+_33005020 | 2.70 |
ENST00000373510.4
ENST00000316459.4 |
ZBTB8A
|
zinc finger and BTB domain containing 8A |
chr12_-_121342170 | 2.70 |
ENST00000353487.2
|
SPPL3
|
signal peptide peptidase like 3 |
chr8_+_75736761 | 2.67 |
ENST00000260113.2
|
PI15
|
peptidase inhibitor 15 |
chr10_-_94003003 | 2.62 |
ENST00000412050.4
|
CPEB3
|
cytoplasmic polyadenylation element binding protein 3 |
chr3_+_141205852 | 2.60 |
ENST00000286364.3
ENST00000452898.1 |
RASA2
|
RAS p21 protein activator 2 |
chr3_+_186648274 | 2.56 |
ENST00000169298.3
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
chr14_+_33408449 | 2.52 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
chr4_+_48018781 | 2.51 |
ENST00000295461.5
|
NIPAL1
|
NIPA-like domain containing 1 |
chr4_+_38665810 | 2.43 |
ENST00000261438.5
ENST00000514033.1 |
KLF3
|
Kruppel-like factor 3 (basic) |
chr20_-_10654639 | 2.32 |
ENST00000254958.5
|
JAG1
|
jagged 1 |
chr15_-_42840961 | 2.30 |
ENST00000563454.1
ENST00000397130.3 ENST00000570160.1 ENST00000323443.2 |
LRRC57
|
leucine rich repeat containing 57 |
chr2_+_148602058 | 2.26 |
ENST00000241416.7
ENST00000535787.1 ENST00000404590.1 |
ACVR2A
|
activin A receptor, type IIA |
chr3_+_30648066 | 2.26 |
ENST00000359013.4
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr2_-_218808771 | 2.18 |
ENST00000449814.1
ENST00000171887.4 |
TNS1
|
tensin 1 |
chr2_+_86947296 | 2.13 |
ENST00000283632.4
|
RMND5A
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
chr19_+_1286097 | 2.08 |
ENST00000215368.2
|
EFNA2
|
ephrin-A2 |
chr10_+_75757863 | 1.98 |
ENST00000372755.3
ENST00000211998.4 ENST00000417648.2 |
VCL
|
vinculin |
chr17_+_21187976 | 1.96 |
ENST00000342679.4
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr7_-_91875358 | 1.91 |
ENST00000458177.1
ENST00000394507.1 ENST00000340022.2 ENST00000444960.1 |
KRIT1
|
KRIT1, ankyrin repeat containing |
chr10_+_76871454 | 1.89 |
ENST00000372687.4
|
SAMD8
|
sterile alpha motif domain containing 8 |
chr11_-_130786400 | 1.87 |
ENST00000265909.4
|
SNX19
|
sorting nexin 19 |
chr18_+_67956135 | 1.85 |
ENST00000397942.3
|
SOCS6
|
suppressor of cytokine signaling 6 |
chr14_-_99737565 | 1.84 |
ENST00000357195.3
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein) |
chr20_-_3996036 | 1.83 |
ENST00000336095.6
|
RNF24
|
ring finger protein 24 |
chr20_-_23030296 | 1.83 |
ENST00000377103.2
|
THBD
|
thrombomodulin |
chr5_+_67511524 | 1.76 |
ENST00000521381.1
ENST00000521657.1 |
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chr10_-_3827417 | 1.70 |
ENST00000497571.1
ENST00000542957.1 |
KLF6
|
Kruppel-like factor 6 |
chr2_+_70142189 | 1.70 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
chr12_+_69864129 | 1.69 |
ENST00000547219.1
ENST00000299293.2 ENST00000549921.1 ENST00000550316.1 ENST00000548154.1 ENST00000547414.1 ENST00000550389.1 ENST00000550937.1 ENST00000549092.1 ENST00000550169.1 |
FRS2
|
fibroblast growth factor receptor substrate 2 |
chr7_-_113559104 | 1.61 |
ENST00000284601.3
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A |
chr12_+_5019061 | 1.61 |
ENST00000382545.3
|
KCNA1
|
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) |
chr12_-_12419703 | 1.60 |
ENST00000543091.1
ENST00000261349.4 |
LRP6
|
low density lipoprotein receptor-related protein 6 |
chr15_-_38856836 | 1.53 |
ENST00000450598.2
ENST00000559830.1 ENST00000558164.1 ENST00000310803.5 |
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
chrX_-_19140677 | 1.52 |
ENST00000357544.3
ENST00000379869.3 ENST00000360279.4 ENST00000379873.2 ENST00000379878.3 ENST00000354791.3 ENST00000379876.1 |
GPR64
|
G protein-coupled receptor 64 |
chr3_-_48229846 | 1.52 |
ENST00000302506.3
ENST00000351231.3 ENST00000437972.1 |
CDC25A
|
cell division cycle 25A |
chr8_-_10588010 | 1.50 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
chr4_-_111544254 | 1.50 |
ENST00000306732.3
|
PITX2
|
paired-like homeodomain 2 |
chr5_-_54281491 | 1.49 |
ENST00000381405.4
|
ESM1
|
endothelial cell-specific molecule 1 |
chr8_+_56014949 | 1.44 |
ENST00000327381.6
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4 |
chr12_-_117319236 | 1.41 |
ENST00000257572.5
|
HRK
|
harakiri, BCL2 interacting protein (contains only BH3 domain) |
chr11_-_1593150 | 1.40 |
ENST00000397374.3
|
DUSP8
|
dual specificity phosphatase 8 |
chr10_+_98741041 | 1.38 |
ENST00000286067.2
|
C10orf12
|
chromosome 10 open reading frame 12 |
chr17_-_33416231 | 1.38 |
ENST00000584655.1
ENST00000447669.2 ENST00000315249.7 |
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
chr12_+_85673868 | 1.37 |
ENST00000316824.3
|
ALX1
|
ALX homeobox 1 |
chr2_-_71454185 | 1.35 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
chr15_+_59063478 | 1.33 |
ENST00000559228.1
ENST00000450403.2 |
FAM63B
|
family with sequence similarity 63, member B |
chr15_-_55881135 | 1.31 |
ENST00000302000.6
|
PYGO1
|
pygopus family PHD finger 1 |
chr6_+_142468361 | 1.30 |
ENST00000367630.4
|
VTA1
|
vesicle (multivesicular body) trafficking 1 |
chr16_+_57392684 | 1.28 |
ENST00000219235.4
|
CCL22
|
chemokine (C-C motif) ligand 22 |
chr3_+_159706537 | 1.22 |
ENST00000305579.2
ENST00000480787.1 ENST00000466512.1 |
IL12A
|
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
chr22_+_40573921 | 1.21 |
ENST00000454349.2
ENST00000335727.9 |
TNRC6B
|
trinucleotide repeat containing 6B |
chr4_+_144257915 | 1.19 |
ENST00000262995.4
|
GAB1
|
GRB2-associated binding protein 1 |
chr2_-_69870835 | 1.13 |
ENST00000409085.4
ENST00000406297.3 |
AAK1
|
AP2 associated kinase 1 |
chr5_+_172483347 | 1.07 |
ENST00000522692.1
ENST00000296953.2 ENST00000540014.1 ENST00000520420.1 |
CREBRF
|
CREB3 regulatory factor |
chr18_-_60987220 | 1.07 |
ENST00000398117.1
|
BCL2
|
B-cell CLL/lymphoma 2 |
chr2_+_45878790 | 1.03 |
ENST00000306156.3
|
PRKCE
|
protein kinase C, epsilon |
chr18_-_29522989 | 1.01 |
ENST00000582539.1
ENST00000283351.4 ENST00000582513.1 |
TRAPPC8
|
trafficking protein particle complex 8 |
chr3_+_29322803 | 1.01 |
ENST00000396583.3
ENST00000383767.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr6_-_82462425 | 1.00 |
ENST00000369754.3
ENST00000320172.6 ENST00000369756.3 |
FAM46A
|
family with sequence similarity 46, member A |
chr22_+_39101728 | 0.99 |
ENST00000216044.5
ENST00000484657.1 |
GTPBP1
|
GTP binding protein 1 |
chr12_+_65563329 | 0.97 |
ENST00000308330.2
|
LEMD3
|
LEM domain containing 3 |
chr11_+_32851487 | 0.88 |
ENST00000257836.3
|
PRRG4
|
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) |
chr1_+_64239657 | 0.88 |
ENST00000371080.1
ENST00000371079.1 |
ROR1
|
receptor tyrosine kinase-like orphan receptor 1 |
chr17_+_35766965 | 0.87 |
ENST00000394395.2
ENST00000589153.1 ENST00000586023.1 |
TADA2A
|
transcriptional adaptor 2A |
chr4_-_140098339 | 0.87 |
ENST00000394235.2
|
ELF2
|
E74-like factor 2 (ets domain transcription factor) |
chr1_+_154377669 | 0.83 |
ENST00000368485.3
ENST00000344086.4 |
IL6R
|
interleukin 6 receptor |
chr16_-_4897266 | 0.82 |
ENST00000591451.1
ENST00000436648.5 ENST00000381983.3 ENST00000588297.1 ENST00000321919.9 |
GLYR1
|
glyoxylate reductase 1 homolog (Arabidopsis) |
chr3_+_98451275 | 0.79 |
ENST00000265261.6
ENST00000497008.1 |
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
chr2_+_20646824 | 0.79 |
ENST00000272233.4
|
RHOB
|
ras homolog family member B |
chr5_+_170846640 | 0.79 |
ENST00000274625.5
|
FGF18
|
fibroblast growth factor 18 |
chr4_-_89744457 | 0.78 |
ENST00000395002.2
|
FAM13A
|
family with sequence similarity 13, member A |
chr9_-_16870704 | 0.75 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr4_+_86396265 | 0.74 |
ENST00000395184.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
chr12_+_12764773 | 0.73 |
ENST00000228865.2
|
CREBL2
|
cAMP responsive element binding protein-like 2 |
chr12_+_5541267 | 0.72 |
ENST00000423158.3
|
NTF3
|
neurotrophin 3 |
chr1_-_115053781 | 0.70 |
ENST00000358465.2
ENST00000369543.2 |
TRIM33
|
tripartite motif containing 33 |
chr7_+_11013491 | 0.68 |
ENST00000403050.3
ENST00000445996.2 |
PHF14
|
PHD finger protein 14 |
chr4_+_81951957 | 0.66 |
ENST00000282701.2
|
BMP3
|
bone morphogenetic protein 3 |
chr14_+_57046500 | 0.65 |
ENST00000261556.6
|
TMEM260
|
transmembrane protein 260 |
chr1_+_172628154 | 0.65 |
ENST00000340030.3
ENST00000367721.2 |
FASLG
|
Fas ligand (TNF superfamily, member 6) |
chr8_-_41909496 | 0.63 |
ENST00000265713.2
ENST00000406337.1 ENST00000396930.3 ENST00000485568.1 ENST00000426524.1 |
KAT6A
|
K(lysine) acetyltransferase 6A |
chr17_+_58755184 | 0.60 |
ENST00000589222.1
ENST00000407086.3 ENST00000390652.5 |
BCAS3
|
breast carcinoma amplified sequence 3 |
chr16_+_69599861 | 0.60 |
ENST00000354436.2
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive |
chr11_+_120207787 | 0.59 |
ENST00000397843.2
ENST00000356641.3 |
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12 |
chr10_-_35930219 | 0.59 |
ENST00000374694.1
|
FZD8
|
frizzled family receptor 8 |
chr17_+_46184911 | 0.59 |
ENST00000580219.1
ENST00000452859.2 ENST00000393405.2 ENST00000439357.2 ENST00000359238.2 |
SNX11
|
sorting nexin 11 |
chr9_-_123476719 | 0.59 |
ENST00000373930.3
|
MEGF9
|
multiple EGF-like-domains 9 |
chr1_+_2160134 | 0.58 |
ENST00000378536.4
|
SKI
|
v-ski avian sarcoma viral oncogene homolog |
chr7_-_92463210 | 0.57 |
ENST00000265734.4
|
CDK6
|
cyclin-dependent kinase 6 |
chr12_-_9913489 | 0.54 |
ENST00000228434.3
ENST00000536709.1 |
CD69
|
CD69 molecule |
chr12_-_42538657 | 0.53 |
ENST00000398675.3
|
GXYLT1
|
glucoside xylosyltransferase 1 |
chr4_-_100867864 | 0.51 |
ENST00000442697.2
|
DNAJB14
|
DnaJ (Hsp40) homolog, subfamily B, member 14 |
chr15_-_102029873 | 0.51 |
ENST00000348070.1
ENST00000358417.3 ENST00000344273.2 |
PCSK6
|
proprotein convertase subtilisin/kexin type 6 |
chr7_-_81399438 | 0.51 |
ENST00000222390.5
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor) |
chr1_-_115632035 | 0.51 |
ENST00000433172.1
ENST00000369514.2 ENST00000369516.2 ENST00000369515.2 |
TSPAN2
|
tetraspanin 2 |
chr12_-_40013553 | 0.49 |
ENST00000308666.3
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2 |
chr2_+_70314579 | 0.49 |
ENST00000303577.5
|
PCBP1
|
poly(rC) binding protein 1 |
chr1_+_213123915 | 0.47 |
ENST00000366968.4
ENST00000490792.1 |
VASH2
|
vasohibin 2 |
chr13_-_110959478 | 0.43 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
chr8_+_87354945 | 0.42 |
ENST00000517970.1
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1 |
chr11_-_44331679 | 0.40 |
ENST00000329255.3
|
ALX4
|
ALX homeobox 4 |
chr1_+_222791417 | 0.40 |
ENST00000344922.5
ENST00000344441.6 ENST00000344507.1 |
MIA3
|
melanoma inhibitory activity family, member 3 |
chr9_-_34589700 | 0.39 |
ENST00000351266.4
|
CNTFR
|
ciliary neurotrophic factor receptor |
chr17_+_61627814 | 0.39 |
ENST00000310827.4
ENST00000431926.1 ENST00000415273.2 |
DCAF7
|
DDB1 and CUL4 associated factor 7 |
chr5_+_154238096 | 0.39 |
ENST00000517568.1
ENST00000524105.1 ENST00000285896.6 |
CNOT8
|
CCR4-NOT transcription complex, subunit 8 |
chr1_-_214724566 | 0.38 |
ENST00000366956.5
|
PTPN14
|
protein tyrosine phosphatase, non-receptor type 14 |
chr8_+_9413410 | 0.37 |
ENST00000520408.1
ENST00000310430.6 ENST00000522110.1 |
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
chr7_+_89975979 | 0.34 |
ENST00000257659.8
ENST00000222511.6 ENST00000417207.1 |
GTPBP10
|
GTP-binding protein 10 (putative) |
chrX_+_46696372 | 0.31 |
ENST00000218340.3
|
RP2
|
retinitis pigmentosa 2 (X-linked recessive) |
chr3_+_181429704 | 0.29 |
ENST00000431565.2
ENST00000325404.1 |
SOX2
|
SRY (sex determining region Y)-box 2 |
chr1_+_36273743 | 0.27 |
ENST00000373210.3
|
AGO4
|
argonaute RISC catalytic component 4 |
chr13_-_36920420 | 0.12 |
ENST00000438666.2
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome) |
chr19_+_14492247 | 0.08 |
ENST00000357355.3
ENST00000592261.2 ENST00000242786.5 |
CD97
|
CD97 molecule |
chr5_+_139493665 | 0.06 |
ENST00000331327.3
|
PURA
|
purine-rich element binding protein A |
chr2_+_228678550 | 0.00 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 13.0 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
2.2 | 8.9 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.5 | 4.6 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
1.5 | 4.4 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
1.3 | 5.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.2 | 3.7 | GO:0008050 | female courtship behavior(GO:0008050) |
1.1 | 4.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.0 | 6.7 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.9 | 2.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.8 | 3.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.8 | 2.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 2.3 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.6 | 1.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.6 | 3.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.6 | 1.7 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.5 | 1.6 | GO:0090244 | trachea cartilage morphogenesis(GO:0060535) Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 4.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.5 | 1.5 | GO:0060577 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.5 | 7.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.5 | 1.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 3.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 2.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.4 | 5.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.4 | 1.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.3 | 1.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 2.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 4.4 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.3 | 0.8 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 5.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 1.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 4.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 2.0 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 1.0 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 1.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 3.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.7 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.2 | 0.6 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.2 | 1.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 2.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 3.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 4.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 1.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 0.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.2 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.6 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.1 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 1.8 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 2.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 2.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.5 | GO:0032898 | nerve growth factor processing(GO:0032455) neurotrophin production(GO:0032898) |
0.1 | 1.3 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 4.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.1 | 1.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 6.1 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 2.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.5 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 1.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 3.2 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.1 | 3.0 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.1 | 3.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 1.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 1.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.9 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 5.3 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.0 | 1.5 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.8 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 2.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 1.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 1.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.9 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.4 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 2.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 1.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 7.1 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
0.0 | 0.1 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.0 | 0.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 0.7 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 1.0 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.4 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 1.5 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.6 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 3.6 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 1.0 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.5 | GO:0045026 | plasma membrane fusion(GO:0045026) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 2.1 | GO:0034657 | GID complex(GO:0034657) |
0.7 | 3.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.6 | 2.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 7.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.5 | 8.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 1.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.4 | 2.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.4 | 4.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 3.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 2.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 1.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 6.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 8.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 5.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 2.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 2.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 4.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 1.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.2 | GO:0031906 | late endosome lumen(GO:0031906) |
0.1 | 0.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 5.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.6 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 9.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 1.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.0 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 1.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 1.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 5.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 3.3 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.8 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 4.1 | GO:0045121 | membrane raft(GO:0045121) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 1.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 5.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 2.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 16.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
1.1 | 4.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.9 | 2.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.7 | 5.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.7 | 2.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 1.9 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.6 | 2.3 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.5 | 8.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 12.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 1.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.5 | 5.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 2.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 3.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 6.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 2.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.3 | 6.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 4.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.8 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.0 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 3.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 0.8 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.2 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 2.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 3.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 4.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 1.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 21.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 6.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 2.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.5 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 1.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 7.2 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 1.2 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 1.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 7.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 3.5 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 1.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 3.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 4.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 12.7 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 1.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 1.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 1.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 7.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 4.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 7.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 3.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 6.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 6.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 2.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 2.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 9.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 2.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 2.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 2.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 6.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 5.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 4.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 3.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 2.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 2.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 6.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 3.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 3.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 2.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 3.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |